Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CYBO is a Japanese healthtech and medical device company developing AI-enabled cell analysis and digital cytology systems. Its core products include CYBO Scan, a 3D digital imaging system for cytology specimens, and CYBO View, a browser-based viewer for 3D whole-slide images, which together support remote review and AI-assisted cervical cancer screening. The company has also developed ENMA, an image-activated cell sorter, and SHIGI, a high-speed 3D cell scanner, leveraging high-speed imaging, real-time AI, and precision mechanical control. Beyond cytology, CYBO is pursuing platelet activation analysis as a potential early biomarker approach for atherothrombotic diseases such as stroke and myocardial infarction. The company appears to be operating commercially in Japan while continuing product development and applied research collaborations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CYBO.